Nutritional Therapy
Home | Online Catalog | Newsletters | Therapy Index | Psoriasis / Eczema | Free Vitamins | Order | Contact Us
Condition: CANDIDASIS (YEAST INFECTION)
SUGGESTED NUTRITION:
Caprylate Complex #920
9 per day. A candidacide that kills off the candida overgrowth.

Acidophilus E.C. #846
3 per day. Candida antagonist. Enteric coated capsule ensures full potency dosage into the colon. Restores intestinal flora.

Multi-Dophilus #963
½ teaspoon per day. Candida antagonist with synergistic blend of Lactobacillus Acidophilus, Bifidobacteria, and Bifido Longum in 900 mg. of fructo-oligosaccharide as the carrier. Dairy free Keep refrigerated Restores intestinal flora.

To order any of these products, click the blue link and use our online shopping cart. All of our products are manufactured in a US FDA approved facility.

PATHOLOGICAL CONSIDERATIONS:
Candida Albicans is a saprophytic yeast that proliferates in the host when the environment becomes favorable and the host's defenses are weakened. The sites most favorable are usually mucocutaneous areas where heat and moisture provide a fertile environment and where various conditions of general disease increase susceptibility to this condition.

PHYSIOLOGICAL CONSIDERATIONS:
The manifestations vary with the site of infection, the most common appearing as erythematous, well-demarcated, exudous patches of varying shape and size. Candida can appear in any number of sites, especially the vagina, groin and gluteal folds, umbilicus, inframammary areas, and even between toes and fingers. Oral candidiasis appears as Thrush with creamy white patches of exudate and can appear around the fingernail as candidal paronychia.

TREATMENT:
Candidal infections develop in environments that are moist and alkaline in nature, in nutritional and immune deficiencies, diabetes, administration of antibiotics and certain endocrine-metabolic abnormalities. These conditions must be cleared up and resolved in order for the actual treatment to be effective.
 
Copyright © 1996-2007 Nutrimed Labs, Inc.